Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gleevec in Active Diffuse Scleroderma
NCT01545427Phase 2Terminated
- Start
- Apr 2008
- Primary completion
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of imatinib in diffuse cutaneous systemic sclerosis (dcSSc). Started Apr 2008; status: terminated.
02
Drugs
03
Conditions
diffuse cutaneous systemic sclerosis (dcSSc)
Beyond the preview
Go deeper on NCT01545427.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01545427.